Pseudoprogression as an adverse event of glioblastoma therapy.

In consistent with previous reports 4 , 5 , 16 , 17 , none of the IDH1‐mutated patients had eP (see Table 1 )and patients undergoing gross total resection showed a trend toward a lower probability of having either PsP or eP.

also in 53,322 other papers